Literature DB >> 24091585

Abnormal cardiac enzymes in systemic sclerosis: a report of four patients and review of the literature.

B Vasta1, V Flower, C Bucciarelli-Ducci, S Brown, E Korendowych, N J McHugh, J D Pauling.   

Abstract

Cardiac involvement in systemic sclerosis (SSc) is heterogeneous and can include primary involvement of the myocardium, pericardium and coronary arteries or be secondary to cardiac complications of pulmonary and renal disease. Primary cardiac involvement in SSc is uncommon but can result in ventricular dysfunction, organ failure, arrhythmias and death. It can remain clinically silent and the prevalence is likely to be under-reported. We report four cases of SSc associated with a raised serum troponin T (TnT), in a proportion of whom cardiac MRI myocardial abnormalities were detected. These cases highlight the heterogeneity of cardiac involvement in SSc, the role of cardiac MRI and promising biochemical responses to immunosuppression. Cardiac biomarkers such as TnT may be useful screening tools to identify subclinical cardiac disease and assess response to therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24091585     DOI: 10.1007/s10067-013-2405-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Development of the cardiac troponin T immunoassay.

Authors:  Hugo A Katus
Journal:  Clin Chem       Date:  2008-09       Impact factor: 8.327

2.  Endocardial and myocardial involvement in systemic sclerosis--is there a relevant inflammatory component?

Authors:  Robert Dinser; Marc Frerix; Florian M P Meier; Karin Klingel; Andreas Rolf
Journal:  Joint Bone Spine       Date:  2012-12-10       Impact factor: 4.929

3.  Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients.

Authors:  T A Medsger; A T Masi
Journal:  J Chronic Dis       Date:  1973-10

Review 4.  Primary myocardial involvement in systemic sclerosis.

Authors:  A Kahan; Y Allanore
Journal:  Rheumatology (Oxford)       Date:  2006-10       Impact factor: 7.580

5.  Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.

Authors:  Anthony J Tyndall; Bettina Bannert; Madelon Vonk; Paolo Airò; Franco Cozzi; Patricia E Carreira; Dominique Farge Bancel; Yannick Allanore; Ulf Müller-Ladner; Oliver Distler; Florenzo Iannone; Raffaele Pellerito; Margarita Pileckyte; Irene Miniati; Lidia Ananieva; Alexandra Balbir Gurman; Nemanja Damjanov; Adelheid Mueller; Gabriele Valentini; Gabriela Riemekasten; Mohammed Tikly; Laura Hummers; Maria J S Henriques; Paola Caramaschi; Agneta Scheja; Blaz Rozman; Evelien Ton; Gábor Kumánovics; Bernard Coleiro; Eva Feierl; Gabriella Szucs; Carlos Alberto Von Mühlen; Valeria Riccieri; Srdan Novak; Carlo Chizzolini; Anna Kotulska; Christopher Denton; Paulo C Coelho; Ina Kötter; Ismail Simsek; Paloma García de la Pena Lefebvre; Eric Hachulla; James R Seibold; Simona Rednic; Jirí Stork; Jadranka Morovic-Vergles; Ulrich A Walker
Journal:  Ann Rheum Dis       Date:  2010-06-15       Impact factor: 19.103

6.  Evaluation of cardiac laboratory markers in patients with systemic sclerosis.

Authors:  Martina Montagnana; Giuseppe Lippi; Alessandro Volpe; Gian Luca Salvagno; Domenico Biasi; Paola Caramaschi; Gian Cesare Guidi
Journal:  Clin Biochem       Date:  2006-04-21       Impact factor: 3.281

7.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

Authors:  P J Clements; P A Lachenbruch; J R Seibold; B Zee; V D Steen; P Brennan; A J Silman; N Allegar; J Varga; M Massa
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

8.  Myocardial involvement in systemic sclerosis.

Authors:  L Belloli; N Carlo-Stella; G Ciocia; A Chiti; M Massarotti; B Marasini
Journal:  Rheumatology (Oxford)       Date:  2008-05-25       Impact factor: 7.580

Review 9.  The heart in scleroderma.

Authors:  Hunter C Champion
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

10.  Myocardial gallium-67 citrate scintigraphy in patients with systemic sclerosis.

Authors:  J Gaál; I Hegedüs; K Dévényi; L Czirják
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

View more
  3 in total

Review 1.  Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity.

Authors:  Michael Hughes; James B Lilleker; Ariane L Herrick; Hector Chinoy
Journal:  Ann Rheum Dis       Date:  2015-03-02       Impact factor: 19.103

2.  Organ Manifestation and Systematic Organ Screening at the Onset of Inflammatory Rheumatic Diseases.

Authors:  Tobias Hoffmann; Peter Oelzner; Martin Busch; Marcus Franz; Ulf Teichgräber; Claus Kroegel; Paul Christian Schulze; Gunter Wolf; Alexander Pfeil
Journal:  Diagnostics (Basel)       Date:  2021-12-29

Review 3.  Sclerodermic Cardiomyopathy-A State-of-the-Art Review.

Authors:  Adrian Giucă; Tea Gegenava; Carmen Marina Mihai; Ciprian Jurcuţ; Adrian Săftoiu; Diana Monica Gȋrniţă; Bogdan Alexandru Popescu; Nina Ajmone Marsan; Ruxandra Jurcuț
Journal:  Diagnostics (Basel)       Date:  2022-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.